Ignite Creation Date:
2024-05-06 @ 5:50 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05453903
Status:
RECRUITING
Last Update Posted:
2024-05-23
First Post:
2022-07-08
Brief Title:
A Study of Bleximenib in Combination With Acute Myeloid Leukemia AML Directed Therapies
Sponsor:
Janssen Research Development LLC
Organization:
Janssen Research Development LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia Myeloid Acute |
Keywords: